Natco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NATCO, and what generic and branded alternatives to NATCO drugs are available?
NATCO has thirty-seven approved drugs.
There are three tentative approvals on NATCO drugs.
Summary for Natco
US Patents: | 0 |
Tradenames: | 34 |
Ingredients: | 34 |
NDAs: | 37 |
Patent Litigation for Natco: | See patent lawsuits for Natco |
Drugs and US Patents for Natco
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Natco Pharma Usa | CARBOPLATIN | carboplatin | INJECTABLE;INJECTION | 091510-002 | May 29, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Natco Pharma Ltd | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 208488-003 | Nov 5, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Natco Pharma Usa | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; olmesartan medoxomil | TABLET;ORAL | 078827-003 | Oct 26, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.